Grant: Planning and Dissemination Grant - Institute Community Support
University of Alberta
$10,000.00
Update to the Canadian Clinical Practice Guideline for Best-practice Management of Breast Cancer Related Lymphedema
FY 2021-22
Summary
Lymphedema, a significant swelling of the arm that occurs on the side of the breast cancer, is one of the more frequent and feared complications following surgery for breast cancer. It is a lifelong condition affecting approximately 20% of women who undergo treatment for their breast cancer. In 2001, an expert panel of clinicians from across Canada published the first Canadian Clinical Practice Guideline for the care and treatment of breast cancer related lymphedema. Given advances in the field over the last 20 years, an update to the guideline is long overdue.
Prior to undertaking the proposed guideline update, a meeting was held involving researchers and clinicians with expertise in breast cancer related lymphedema, as well as patient representatives. Twenty stakeholders from across Canada took part in the initial meeting. A framework for the updated guideline was developed based on four main categories: 1) diagnosis, 2) risk reduction, 3) management, 4) measurement outcomes and surveillance.
Our team has completed of a comprehensive literature review and appraisal of existing guidelines from other countries using the AGREE II tool. We are currently working to adapt, amalgamate and incorporate recommendations for the Canadian guideline.
The objective of the proposed meeting and associated activities is to detail a plan for dissemination of the guideline recommendations. Specifically, we aim to:
1. Obtain feedback on the draft updated guideline from international experts and stakeholder groups.
2. Disseminate findings to stakeholder groups through webinars, conferences, social media platforms and an open-access publication.
3. Create of a series of four 1-to-2 minute video presentations of guideline recommendations in both official languages.
Through this work, we aim to provide updated recommendations to individuals with, and at risk of lymphedema and their physicians on the diagnosis, risk reduction and management of breast cancer related lymphedema.
Department
Program
Planning and Dissemination Grant - Institute Community Support
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
460954
Name
Mcneely Margaret L
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Clinical
Prcname2
Planning and Dissemination - ICR
Projecttitle
Update to the Canadian Clinical Practice Guideline for Best-practice Management of Breast Cancer Related Lymphedema
Programtype2
Miscellaneous Programs
Orgnameinp2
University of Alberta
Cihramount2
$10,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Breast Cancer; Lymphedema
Abstract
Lymphedema, a significant swelling of the arm that occurs on the side of the breast cancer, is one of the more frequent and feared complications following surgery for breast cancer. It is a lifelong condition affecting approximately 20% of women who undergo treatment for their breast cancer. In 2001, an expert panel of clinicians from across Canada published the first Canadian Clinical Practice Guideline for the care and treatment of breast cancer related lymphedema. Given advances in the field over the last 20 years, an update to the guideline is long overdue.
Prior to undertaking the proposed guideline update, a meeting was held involving researchers and clinicians with expertise in breast cancer related lymphedema, as well as patient representatives. Twenty stakeholders from across Canada took part in the initial meeting. A framework for the updated guideline was developed based on four main categories: 1) diagnosis, 2) risk reduction, 3) management, 4) measurement outcomes and surveillance.
Our team has completed of a comprehensive literature review and appraisal of existing guidelines from other countries using the AGREE II tool. We are currently working to adapt, amalgamate and incorporate recommendations for the Canadian guideline.
The objective of the proposed meeting and associated activities is to detail a plan for dissemination of the guideline recommendations. Specifically, we aim to:
1. Obtain feedback on the draft updated guideline from international experts and stakeholder groups.
2. Disseminate findings to stakeholder groups through webinars, conferences, social media platforms and an open-access publication.
3. Create of a series of four 1-to-2 minute video presentations of guideline recommendations in both official languages.
Through this work, we aim to provide updated recommendations to individuals with, and at risk of lymphedema and their physicians on the diagnosis, risk reduction and management of breast cancer related lymphedema.
Competitiondate
202202
Approvedterm2
1 yr 0 mth
Pinamesdelim
Mcneely, Margaret L
Approvedterm
1 an 0 mois
Cihrcontribution2
Inst of Cancer Research~ $10,000~ $0~